Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Differences in IgG subclass do not effect immune complex-enhanced T cell activation despite differential binding to

D M Jelley-Gibbs1, L M Plitnick, E J Gosselin

  • 1Department of Microbiology, Immunology, and Molecular Genetics, Albany Medical College, NY 12208, USA.

Human Immunology
|July 17, 1999
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cytokine mRNA profiles for isocyanates with known and unknown potential to induce respiratory sensitization.

Toxicology·2005
Same author

Identifying airway sensitizers: cytokine mRNA profiles induced by various anhydrides.

Toxicology·2003
Same author

Cytokine profiling for chemical sensitizers: application of the ribonuclease protection assay and effect of dose.

Toxicology and applied pharmacology·2002
Same author

Lipoteichoic acid inhibits interleukin-2 (IL-2) function by direct binding to IL-2.

Clinical and diagnostic laboratory immunology·2001
Same author

Two distinct stages in the transition from naive CD4 T cells to effectors, early antigen-dependent and late cytokine-driven expansion and differentiation.

Journal of immunology (Baltimore, Md. : 1950)·2000
Same author

Stealth cells: prevention of major histocompatibility complex class II-mediated T-cell activation by cell surface modification.

Blood·1999

Human IgG subclasses (IgG1-4) equally enhance T cell activation despite differences in FcgammaR binding. A selective processing pathway compensates for lower binding by IgG2 and IgG4, ensuring effective antigen presentation.

Area of Science:

  • Immunology
  • Cellular Biology

Background:

  • Antigen (Ag) presentation to CD4 T cells is crucial for immunity.
  • Immunoglobulin G (IgG) complexes can enhance Ag presentation via Fcgamma receptors (FcgammaR).
  • Understanding human IgG subclass function in T cell activation is important.

Purpose of the Study:

  • To investigate the role of individual human IgG subclasses in FcgammaR-dependent Ag presentation and T cell activation.
  • To test the hypothesis that high-affinity IgG subclasses (IgG1, IgG3) enhance Ag presentation more than low-affinity subclasses (IgG2, IgG4).

Main Methods:

  • Immune complexes were formed by linking biotinylated IgG subclasses to biotinylated Ag via an avidin bridge.
  • Monocyte binding of IgG-Ag complexes was measured.
  • T cell responses to these complexes were examined.

Related Experiment Videos

Main Results:

  • IgG1 and IgG3 complexes showed significantly higher binding to monocytes than IgG2 and IgG4 complexes.
  • Despite differential binding, all four human IgG subclasses mediated comparable enhanced T cell activation.
  • Ag processing efficiency within the first 24 hours varied by IgG subclass.

Conclusions:

  • Human IgG subclasses exhibit similar efficacy in enhancing T cell activation, irrespective of FcgammaR binding levels.
  • A selective and efficient Ag processing pathway, dependent on IgG subclass, compensates for lower FcgammaR binding of IgG2 and IgG4.
  • This pathway ensures effective Ag presentation and T cell activation even with reduced IgG-Ag complex binding.